Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Guillaume Bonnefois"'
Autor:
Nassim Djebli, Pierre-Olivier Tremblay, Vincent Buchheit, Mario González-Sales, Guillaume Bonnefois, Georgina Meneses-Lorente, Francois Mercier, Nicolas Frey
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:997-1007
Entrectinib (ROZLYTREK®) is a CNS-active, potent, and selective inhibitor of ROS1, TRK A/B/C, and ALK kinase activity. It was recently approved for the treatment of ROS1-positive non-small cell lung cancer and NTRK gene fusion-positive solid tumors.
Autor:
Nathalie H. Gosselin, Ulf Landmesser, Guillaume Bonnefois, Patrick F. Smith, Gregory S. Schwartz, Frederick J. Raal, Lorena Garcia Conde, Kausik K. Ray, Lawrence A. Leiter, R. Scott Wright, Wolfgang Koenig, David Kallend, Laura H Gunn
Publikováno v:
Journal of the American College of Cardiology. 77:1462